Clincosm LogoSign in Get a demo

Alzheimer's Disease

Showing NaN - NaN of 102
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Alzheimer's Disease, Dementia With Lewy Bodies, Parkinson's Disease Dementia Trial in United States (RVT-101 35 mg, Placebo)

Completed
Has Results
  • Alzheimer's Disease
  • +2 more
  • RVT-101 35 mg
  • Placebo
  • Phoenix, Arizona
  • +10 more
Apr 17, 2020

Alzheimer's Disease Trial in Worldwide (RVT-101 35 mg tablets)

Terminated
Has Results
  • Alzheimer's Disease
  • RVT-101 35 mg tablets
  • Phoenix, Arizona
  • +168 more
Apr 14, 2020

Alzheimer's Disease Trial in Worldwide (Crenezumab)

Completed
Has Results
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +85 more
Feb 18, 2020

Alzheimer's Disease Trial in Worldwide (Lanabecestat, Placebo)

Terminated
Has Results
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +261 more
Nov 19, 2019

Alzheimer's Disease Trial in Worldwide (Lanabecestat)

Terminated
Has Results
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +132 more
Nov 19, 2019

Alzheimer's Disease, Pseudobulbar Affect (PBA) Trial in Phoenix (Nuedexta (20/10))

Terminated
  • Alzheimer's Disease
  • Pseudobulbar Affect (PBA)
  • Nuedexta (20/10)
  • Phoenix, Arizona
    Barrow Neurological Institute
Oct 25, 2019

Alzheimer's Disease Trial in Worldwide (Group 1 ELND005, Group 2 ELND005)

Terminated
Has Results
  • Alzheimer's Disease
  • Group 1 ELND005
  • Group 2 ELND005
  • Birmingham, Alabama
  • +45 more
Oct 17, 2019

Alzheimer's Disease Trial in Canada, United States (ELND005 (scyllo-inositol))

Completed
Has Results
  • Alzheimer's Disease
  • ELND005 (scyllo-inositol)
  • Phoenix, Arizona
  • +37 more
Oct 17, 2019

Alzheimer's Disease Trial in Worldwide (ELND005, Placebo)

Completed
Has Results
  • Alzheimer's Disease
  • Birmingham, Alabama
  • +69 more
Oct 17, 2019

Alzheimer's Disease Trial in Worldwide (Solanezumab, Placebo)

Terminated
Has Results
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +192 more
Sep 25, 2019

Alzheimer's Disease Trial in Worldwide (Solanezumab, Placebo)

Terminated
Has Results
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +197 more
Sep 25, 2019

Alzheimer's Disease Trial in Worldwide (Solanezumab, Placebo)

Terminated
Has Results
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +146 more
Sep 25, 2019

Alzheimer's Disease Trial in Canada, United States (AZD0530 100mg daily, AZD0530 125mg daily, Placebo)

Completed
Has Results
  • Alzheimer's Disease
  • AZD0530 100mg daily
  • +2 more
  • Phoenix, Arizona
  • +21 more
Jul 25, 2019

Alzheimer's Disease Trial in United States (T-817MA-H, T-817MA-L, Placebo)

Completed
Has Results
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +49 more
Feb 12, 2019

Alzheimer's Disease Trial in Worldwide (RVT-101, Placebo)

Completed
Has Results
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +196 more
Nov 8, 2018

Alzheimer's Disease Trial in United States (PF-04494700, Placebo)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +61 more
Nov 28, 2018

Alzheimer's Disease Trial in Phoenix, San Francisco (18F-AV-1451)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +1 more
Oct 23, 2018

Alzheimer's Disease Trial in Phoenix (Donepezil TDS)

Completed
  • Alzheimer's Disease
  • Donepezil TDS
  • Phoenix, Arizona
    Celerion
Sep 13, 2018

Alzheimer's Disease Trial in Worldwide (Idalopirdine 60 mg)

Completed
Has Results
  • Alzheimer's Disease
  • Idalopirdine 60 mg
  • Birmingham, Alabama
  • +257 more
Aug 9, 2018

Alzheimer's Disease Trial in Phoenix (Donepezil TDS, Aricept)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
    Celerion Inc.
Jul 31, 2018

Alzheimer's Disease Trial in United States (Bryostatin 1, Placebo)

Completed
Has Results
  • Alzheimer's Disease
  • Bryostatin 1
  • Placebo
  • Phoenix, Arizona
  • +28 more
Jun 6, 2018

Alzheimer's Disease Trial in Worldwide (LY2886721, Placebo)

Terminated
Has Results
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +33 more
May 16, 2018

Alzheimer's Disease Trial in Worldwide (TRx0237 150 mg/day, TRx0237 250 mg/day, Placebo)

Completed
  • Alzheimer's Disease
  • TRx0237 150 mg/day
  • +2 more
  • Phoenix, Arizona
  • +120 more
Mar 12, 2018

Alzheimer's Disease Trial in Worldwide (TRx0237 200 mg/day, Placebo)

Completed
  • Alzheimer's Disease
  • TRx0237 200 mg/day
  • Placebo
  • Phoenix, Arizona
  • +94 more
Mar 12, 2018

Alzheimer's Disease Trial in Worldwide (Placebo, Idalopirdine)

Completed
Has Results
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +161 more
Jan 23, 2018